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Abstract 18 – Table 1. Characteristics of the 13 patients with positive samples for respiratory virus
Patient Sample Virus Symptom/Image Treatment
1 NW IFV A+RSV Coryza, wheezing and dyspnea Oseltamivir
2 BAL hMPV Coryza and sore throat Aciclovir for oral herpes
3 BAL ADV+hMPV Respiratory failure Prophylatic Ganciclovir
4 BAL IFV A Coryza Oseltamivir
5 NW hMPV Coryza and cough None
BAL hMPV Pulmonary nodule None
6 NW IFV A Coryza, cough and fever Oseltamivir
7 NW PIV Intense cough None
8 BAL hMPV Thickened airway at chest CT None
NW PIV Coryza and cough Prophylactic oselltamivir
9 NW IFV A Respiratory failure Oseltamivir
NW hMPV Coryza and cough None
10 NW RSV+hMPV Coryza and cough None
11 BAL hMPV Dyspnea Aciclovir for oral herpes
12 BAL hMPV Bronchi hyperemia Ganciclovir for CMV colitis
13 NW hMPV Coryza and headache None
of RV infection. Other RV identified are shown in table 1. One pa-
tient died because of ADV infection.
Conclusions: Respiratory events are common after LT and may
cause significant morbidity. Rapid diagnosis of RV infections favors
early treatment and may help to differentiate from other condi-
tions. In our country, RV circulate year round, though more fre-
quently during winter months.
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Introduction: An analysis of bacterial infections in the early post-
transplant period after liver transplantation in adults.
Material and Methods: The study covered 83 adult patients un-
dergoing liver transplantation from 2001 to the end of 2004. All
the patients were followed prospectively for infections from the
LT date and during the first four weeks after surgery. Basic im-
munosuppression consisted of steroids and tacrolimus. Antimicro-
bial prophylaxis was administered intravenously from the day of
transplantation: piperacillin/tazobactam, fluconazole and selec-
tive bowel decontamination (orally a liquid suspension of amikacin
and nystatin) was carried out. Samples of clinical materials (blood,
urine, wound swabs, stool and other) were investigated. The mi-
croorganisms were cultured and identified in accordance with stan-
dard bacteriological procedures. Susceptibility testing was carried
out using (NCCLS) procedures. The statistical analysis was made by
chi-square test.
Results: 913 clinical samples taken from liver recipients were in-
vestigated in microbiological laboratory. In total 469 strains were
cultured. Among the bacterial strains, the most common were
Gram-positive bacteria n=331 strains (70.6%), Gram-negative bac-
teria n=133 strains (28.4%) and yeast like fungi n=5 strains (1%).
In the early posttransplant period the common isolates were taken
from Surgical Site Area n=284 (60%) with predomination of Gram-
positive strains n=222 (78%), Gram-negative strains n=61 (21.5%).
From blood n=99 strains (21.1%) were cultured: Gram-positive
n=75 (75.8%) and Gram-negative n=22 (22.2%). Urine samples n=73
(15.6%): among them Gram-negative n=46 (63%), Gram-positive
n=25 (34%), fungi n=2 (3%). Samples taken from respiratory tract
n=13 (2.8%) strains were cultured: Gram-positive n=9 (69%), Gram-
negative n=4 (31%). From 54 stool samples Clostridium difficile
toxins were positive in 63%, only in 16.7% of samples C.difficile
strains were detected, 30% were negative. We analyzed the sus-
ceptibility of cultured strains to antibacterial agents. In total n=10
strains of (MRSA), n=138 of (MRCNS) staphylococci were detected,
86% of enterococci were (HLAR) strains and from Enterobacteri-
aceae family 12.5% (ESBL) rods were detected.
Conclusions: The presence of (MDR) bacterial strains after liver
transplantation such as: methicillin-resistant staphylococci (MRSA)
– 52.6%, (MRCNS) 81.7%, enterococci (HLAR) 86%, enteric Gram-
negative bacteria (ESBL) 12.5% required better professional infec-
tion controls.
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Introduction: Urinary Tract Infection (UTI) is a one of the common
infection in liver transplantation (LT).
Patients and Methods: The study covered 83 adult patients un-
dergoing liver transplantation (piggy back technique) between
September 2001 and October 2004. All the patients were followed
prospectively for urinary tract infections from the LT date and dur-
ing the first four weeks after surgery. Samples of urine were in-
vestigated for bacteriological cultures. The microorganisms were
cultured and identified in accordance with standard bacteriolog-
ical procedures. Susceptibility testing was carried out using Na-
tional Committee for Clinical Laboratory Standards (NCCLS) proce-
dures.
Results: Urine specimens were examined in 53 pre-operative re-
cipients (63.9%) and in 64 patients (77.1%) during the first month
after transplantation. Of the 182 samples investigated, 73 were
positive. Bacterial strains were cultured from 17 recipients before
LT and from 28 patients after surgery. Among the bacterial strains
isolated in early period after LT (n=71), the most common were
Gram-negative rods n=46 (63%) isolates, the Enterobacteriaceae
family n=44 (95.6%) isolates among them n=12 (27.3%) of the Gram-
negative rods were Extended-Spectrum Beta-Lactamases ESBL pos-
S10 Infections in Patients with Solid Organ Transplantation
itive strains. Gram-positive bacteria were cultured 34% (n=25) and
fungal strains 3% (n=2).
Conclusions: The predominance of Gram-negative rods was caused
by ESBL positive and use of broad spectrum antimicrobial prophy-
laxis. The increased proportion of isolation Multi-Drug-Resistant
(MDR) bacteria to antimicrobial agents may be due to the frequent
use of these agents for prophylaxis of bacterial infections in liver
transplant patients. These (MDR) bacterial strains caused severe
UTI' s in patients after LT.
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Introduction: Fungal infection is a severe complication in patients
undergoing solid organ transplantations.
Objective: The objective of the study was to evaluate species dis-
tribution and antifungal susceptibilities of fungal isolates taken
from patients after solid organ transplantation (SOT).
Material and Methods: The study included samples of urine,
blood, systemic fluids and the swabs of the post-operative wounds,
haematomas, drains taken from patients after kidney, liver or si-
multaneous pancreas-kidney transplantation hospitalized in Insti-
tute of Transplantation Medicine, Medical University of Warsaw
and Department of General and Transplantation Surgery, Medical
University of Warsaw in 2005- 2007. All cultured specimens were
isolated by using Sabouraud medium with antibacterial protection
using chloramphenicol and gentamicin (bioMerieux, France or Ox-
oid, England). Yeast-like fungi was incubated on CHROMAgar Can-
dida Medium (Becton Dickinson R) and identified by using biochemi-
cal, automatic test ID32C (bioMerieux). Susceptibility of the strains
to the antifungal agents: amfotericin B, itraconazol, fluconazol,
voriconazol was tested using E-test (AB Biodisk) on RPMI agar plates
(BiolifeR).
Results: The positive cultures were obtained in 662 samples from
402 patients receiving immunosuppressive therapy. There were cul-
tured 267 isolates of Candida albicans, 223 Candida glabrata, 39
strains of C. parapsilosis, 37 C. krusei and 35 of Trichosporon
asahii, 20 Saccharomyces cerevisiae, 9 strains of Cryptococcus neo-
formans 5 C. lipolytica, 6 strains of C. lusitaniae and 4 of C. sake,
5 strain of C. quilliermondii, 3 C. rugosa and 9 moulds from As-
pergillus fumigatus species. From cultured strains 37.3% was natu-
rally fluconazole resistant and 0.5% amphotericin B resistant. The
acquired resistant to fluconazole was presented by 10 isolates, to
itraconazole 26, to voriconazole 2 and to amphotericin B by 3 iso-
lates.
Conclusions: The most numerable groups of isolated fungal species
in patients after SOT were C. albicans 40% of all isolates and
C. glabrata 33.7%. Moulds were cultured less often and they were
found only in 1.4% of positive cultures. More than one third of iso-
lated fungi were resistant to fluconazole.
22
Selection of Resistant Fungi in Liver Transplant Recipients
During use of New Anti-fungal Agents
Ban Hock Tan, Chee Kiat Tan. Singapore General Hospital, Liver
Transplant Service, Singapore, Republic of Singapore
Background: The echinocandins and the new-generation azoles
have been a boon to physicians managing fungal infections in trans-
plant recipients. But Nature abhors a vacuum. In this report, we
describe 2 liver transplant recipients on the new broad-spectrum
anti-fungals who became colonized and infected with fungi resis-
tant to these new agents.
Methods: Retrospective chart review. MIC of Candida spp. to azole
anti-fungals measured by E-test method.
Results: Case 1, a 36-year-old man, received a right-lobe graft
for fulminant hepatic failure, likely drug-induced. The transplant
surgery was complicated by the need for a colostomy. While under
standard immunosuppression, he was given caspofungin (CAS) for
Candida lusitaniae in the bloodstream. Three weeks later blood
cultures grew Trichosporon asahii, which responded to voricona-
zole (VCZ). Case 2 was a 56-year-old man with chronic Hepatitis
B infection and hepatocellular carcinoma, who underwent living
donor liver transplant with a left-lobe graft. He received standard
immunosuppression. In the early post-transplant period, hypoden-
sities developed segment 3, suggestive of infarction. In the 3rd
post-transplant month, the fully-evolved infarcted areas were doc-
umented to be in communication with the biliary tree.
Repeated fevers led to the placement of a biliary drain. Bile aspi-
rated on the 79th post-transplant day (PTD) grew Candida albicans,
and the patient was given fluconazole (FCZ). A cholangiogram on
the 139th PTD led to bile aspiration that cultured out C. albicans
(FCZ MIC 1.5ug/ml) and C. krusei. A septic episode on the 150th
PTD led to the use of VCZ and broad-spectrum antibiotics. Bile as-
pirated on the 160th PTD grew C. glabrata that was resistant to
FCZ, VCZ, itraconazole and posaconazole.
Conclusions: Although CAS and VCZ have been a boon to physi-
cians managing fungal infections, their use can be associated with
the selection of fungi resistant to them. Care with the use of an-
tibiotics should extend to the anti-fungals as well.
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Objectives: To determine the causative agents of urinary tract in-
fections (UTIs) among renal transplant recipients and to compare
the antibiotic susceptibilities of Escherichia coli strains isolated
from complicated community-acquired UTIs and renal transplant
recipients.
Methods: We evaluated 108 episodes of 82 recipients (46 women)
with confirmed UTI who were transplanted during the period 1981
to December 2007 at our center. Medical records of the patients
were reviewed retrospectively. To compare the susceptibility rates
of E. coli, 226 isolates from non-transplant patients with compli-
cated community-acquired UTIs were also evaluated.
Results: The mean age of the patients was 35.9 years in the range
from 16 to 58 years. Sixty-three patients had single episodes. Sev-
enteen episodes (15.7%) occurred in the first month following the
transplantation, 32 (29.6%) in the period of the second month to
sixth month and 59 (54.6%) occurred six months after transplan-
tation. Sixty-six (61.1%) of the 108 isolates were Escherichia coli,
24 (22.2%) Klebsiella spp., 5 (4.6%) Enterococcus spp., 5 (4.6%)
Staphylococcus aureus, 3 (2.8%) Acinetobacter baumannii, 1 (0.9%)
